Acciones de Estados Unidos: empresas por la K
Las cuentas oficiales de 64 empresas de Estados Unidos cuyo nombre empieza por la K: ingresos y beneficio del último ejercicio, tal como figuran en el informe anual (10-K) que cada una presenta ante la SEC, en dólares. Cada una enlaza su ficha, con el documento del que sale cada cifra.
| Empresa | Código | Ejercicio | Ingresos | Beneficio neto |
|---|---|---|---|---|
| Kadant | NYSE: KAI | 2025 | 1.052 M$ | 102,0 M$ |
| Kaiser Aluminum | NASDAQ: KALU | 2025 | 3.373 M$ | 112,5 M$ |
| Kaltura | NASDAQ: KLTR | 2025 | 180,9 M$ | −12,1 M$ |
| Karat Packaging | NASDAQ: KRT | 2025 | 467,7 M$ | 31,5 M$ |
| Karman | NYSE: KRMN | 2025 | 471,5 M$ | 17,4 M$ |
| Karyopharm Therapeutics | NASDAQ: KPTI | 2025 | 146,1 M$ | −196,0 M$ |
| Kayne Anderson BDC | NYSE: KBDC | 2025 | — | 93,7 M$ |
| KB Home | NYSE: KBH | 2025 | 6.236 M$ | 428,8 M$ |
| KBR | NYSE: KBR | 2025 | 7.786 M$ | 415,0 M$ |
| Kearny Financial | NASDAQ: KRNY | 2026 | 178,1 M$ | 36,3 M$ |
| Kelly Services | NASDAQ: KELYA | 2025 | 4.251 M$ | −254,1 M$ |
| Kemper | NYSE: KMPR | 2025 | 4.790 M$ | 143,3 M$ |
| Kennametal | NYSE: KMT | 2026 | 2.357 M$ | 342,4 M$ |
| Kenvue | NYSE: KVUE | 2025 | 15.124 M$ | 1.470 M$ |
| Keros Therapeutics | NASDAQ: KROS | 2025 | 244,1 M$ | 87,0 M$ |
| Kestra Medical Technologies | NASDAQ: KMTS | 2026 | 95,1 M$ | −131,6 M$ |
| Keurig Dr Pepper | NASDAQ: KDP | 2025 | 16.603 M$ | 2.079 M$ |
| KeyCorp | NYSE: KEY | 2025 | 7.513 M$ | 1.829 M$ |
| Keysight Technologies | NYSE: KEYS | 2025 | 5.375 M$ | 850,0 M$ |
| Kforce | NYSE: KFRC | 2025 | 1.329 M$ | 34,8 M$ |
| Kilroy Realty | NYSE: KRC | 2025 | 1.113 M$ | 302,6 M$ |
| Kimball Electronics | NASDAQ: KE | 2026 | 1.431 M$ | 28,0 M$ |
| Kimbell Royalty Partners | NYSE: KRP | 2025 | 333,8 M$ | 99,7 M$ |
| Kimberly-Clark | NASDAQ: KMB | 2025 | 16.447 M$ | 2.021 M$ |
| Kimco Realty | NYSE: KIM | 2025 | 2.140 M$ | 584,7 M$ |
| Kinder Morgan | NYSE: KMI | 2025 | 16.937 M$ | 3.056 M$ |
| KinderCare Learning Companies | NYSE: KLC | 2025 | 2.733 M$ | −112,9 M$ |
| Kinetik | NYSE: KNTK | 2025 | 1.764 M$ | 178,3 M$ |
| Kingstone Companies | NASDAQ: KINS | 2025 | 214,9 M$ | 40,8 M$ |
| Kingsway | NYSE: KWY | 2025 | 135,0 M$ | −10,3 M$ |
| Kiniksa Pharmaceuticals International | NASDAQ: KNSA | 2025 | 677,6 M$ | 59,0 M$ |
| Kinsale Capital Group | NYSE: KNSL | 2025 | 1.874 M$ | 503,6 M$ |
| Kirby | NYSE: KEX | 2025 | 3.364 M$ | 354,6 M$ |
| Kite Realty Group Trust | NYSE: KRG | 2025 | 844,4 M$ | 298,7 M$ |
| KKR | NYSE: KKR | 2025 | 19.464 M$ | 2.370 M$ |
| KKR Real Estate Finance Trust | NYSE: KREF | 2025 | 435,6 M$ | −47,1 M$ |
| KLA | NASDAQ: KLAC | 2026 | 13.579 M$ | 4.831 M$ |
| Klaviyo | NYSE: KVYO | 2025 | 1.234 M$ | −31,8 M$ |
| Knife River | NYSE: KNF | 2025 | 3.146 M$ | 157,1 M$ |
| Knight-Swift Transportation | NYSE: KNX | 2025 | 7.470 M$ | 65,9 M$ |
| Knowles | NYSE: KN | 2025 | 593,2 M$ | 44,2 M$ |
| Kodiak Gas Services | NYSE: KGS | 2025 | 1.308 M$ | 80,5 M$ |
| Kodiak Sciences | NASDAQ: KOD | 2025 | — | −230,0 M$ |
| Kohl’S | NYSE: KSS | 2026 | 15.527 M$ | 272,0 M$ |
| Kontoor Brands | NYSE: KTB | 2025 | 3.152 M$ | 227,5 M$ |
| Kopin | NASDAQ: KOPN | 2025 | 39,3 M$ | 2,6 M$ |
| Koppers | NYSE: KOP | 2025 | 1.879 M$ | 56,0 M$ |
| Korn Ferry | NYSE: KFY | 2026 | 2.939 M$ | 277,4 M$ |
| Korro Bio | NASDAQ: KRRO | 2025 | 6,4 M$ | −117,3 M$ |
| Koru Medical Systems | NASDAQ: KRMD | 2025 | 41,1 M$ | −2,6 M$ |
| Kosmos Energy | NYSE: KOS | 2025 | 1.288 M$ | −699,8 M$ |
| Kraft Heinz | NYSE: KHC | 2025 | 24.942 M$ | −5.846 M$ |
| Kratos Defense & Security Solutions | NASDAQ: KTOS | 2025 | 1.347 M$ | 22,0 M$ |
| Krispy Kreme | NASDAQ: DNUT | 2025 | 1.523 M$ | −515,8 M$ |
| Kroger | NYSE: KR | 2026 | 147.642 M$ | 1.016 M$ |
| Kronos Worldwide | NYSE: KRO | 2025 | 1.859 M$ | −110,9 M$ |
| Krystal Biotech | NASDAQ: KRYS | 2025 | 389,1 M$ | 204,8 M$ |
| Kulicke and Soffa Industries | NASDAQ: KLIC | 2025 | 654,1 M$ | 0,2 M$ |
| Kura Oncology | NASDAQ: KURA | 2025 | 67,5 M$ | −278,7 M$ |
| Kura Sushi USA | NASDAQ: KRUS | 2026 | 328,3 M$ | −4,6 M$ |
| KVH Industries | NASDAQ: KVHI | 2025 | 111,0 M$ | −7,4 M$ |
| Kymera Therapeutics | NASDAQ: KYMR | 2025 | 39,2 M$ | −311,4 M$ |
| Kyndryl | NYSE: KD | 2026 | 15.092 M$ | 198,0 M$ |
| Kyverna Therapeutics | NASDAQ: KYTX | 2025 | — | −161,3 M$ |
Información elaborada con las cuentas que cada empresa presenta ante el regulador, con fines informativos. No es asesoramiento financiero ni una recomendación de compra o venta.